Skip to Main Content

Author Details

David R Hall
Diamond Light Source Ltd, Harwell Science & Innovation Campus
1998
68
35
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33756110The antigenic anatomy of SARS-CoV-2 receptor binding domain.Cell2021
33852911Antibody evasion by the P.1 strain of SARS-CoV-2.Cell2021
33743891Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.Cell2021
33756110The antigenic anatomy of SARS-CoV-2 receptor binding domain.Cell2021
33743891Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.Cell2021
33852911Antibody evasion by the P.1 strain of SARS-CoV-2.Cell2021
32939270Gold Standard for macromolecular crystallography diffraction data.IUCrJ2020
31851823Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).Biochemistry2020
31949913Measuring energy-dependent photoelectron escape in microcrystals.IUCrJ2020
32939270Gold Standard for macromolecular crystallography diffraction data.IUCrJ2020
34895658A comprehensive approach to X-ray crystallography for drug discovery at a synchrotron facility - The example of Diamond Light Source.Drug Discov Today Technol2020
34895658A comprehensive approach to X-ray crystallography for drug discovery at a synchrotron facility - The example of Diamond Light Source.Drug Discov Today Technol2020
31949913Measuring energy-dependent photoelectron escape in microcrystals.IUCrJ2020
31851823Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).Biochemistry2020
30950396How best to use photons.Acta Crystallogr D Struct Biol2019
31274316Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases.J Med Chem2019
30950396How best to use photons.Acta Crystallogr D Struct Biol2019
31274316Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases.J Med Chem2019
29101520Protein-ligand docking using FFT based sampling: D3R case study.J Comput Aided Mol Des2018
29533241Where is crystallography going?Acta Crystallogr D Struct Biol2018
29581267Exploring the structural origins of cryptic sites on proteins.Proc Natl Acad Sci U S A2018
29101520Protein-ligand docking using FFT based sampling: D3R case study.J Comput Aided Mol Des2018
29581267Exploring the structural origins of cryptic sites on proteins.Proc Natl Acad Sci U S A2018
29533241Where is crystallography going?Acta Crystallogr D Struct Biol2018
27771482ClusPro-DC: Dimer Classification by the Cluspro Server for Protein-Protein Docking.J Mol Biol2017
28994793Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092.J Vis Exp2017
27936493New additions to the ClusPro server motivated by CAPRI.Proteins2017
27771482ClusPro-DC: Dimer Classification by the Cluspro Server for Protein-Protein Docking.J Mol Biol2017
28079879The ClusPro web server for protein-protein docking.Nat Protoc2017
28079879The ClusPro web server for protein-protein docking.Nat Protoc2017
28994793Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092.J Vis Exp2017
27936493New additions to the ClusPro server motivated by CAPRI.Proteins2017
26891978Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs.Drug Discov Today2016
26891978Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs.Drug Discov Today2016
27122118Prediction of homoprotein and heteroprotein complexes by protein docking and template-based modeling: A CASP-CAPRI experiment.Proteins2016
27630057The use of fake ligands from computational solvent mapping in ligand and structure-based virtual screening.Future Med Chem2016
27539848Structural Basis for Interactions Between Contactin Family Members and Protein-tyrosine Phosphatase Receptor Type G in Neural Tissues.J Biol Chem2016
27630057The use of fake ligands from computational solvent mapping in ligand and structure-based virtual screening.Future Med Chem2016
27122118Prediction of homoprotein and heteroprotein complexes by protein docking and template-based modeling: A CASP-CAPRI experiment.Proteins2016
27539848Structural Basis for Interactions Between Contactin Family Members and Protein-tyrosine Phosphatase Receptor Type G in Neural Tissues.J Biol Chem2016
25502203Application of in situ diffraction in high-throughput structure determination platforms.Methods Mol Biol2015
25502203Application of in situ diffraction in high-throughput structure determination platforms.Methods Mol Biol2015
25826363Computational solvent mapping in structure-based drug design.Future Med Chem2015
25855957The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins.Nat Protoc2015
26230724New Frontiers in Druggability.J Med Chem2015
26172070Structural and functional characterization of two unusual endonuclease III enzymes from Deinococcus radiodurans.J Struct Biol2015
26538314Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery.Trends Pharmacol Sci2015
26538314Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery.Trends Pharmacol Sci2015
26230724New Frontiers in Druggability.J Med Chem2015
26172070Structural and functional characterization of two unusual endonuclease III enzymes from Deinococcus radiodurans.J Struct Biol2015
  • 1 - 50 of 136

Recommended Authors

Stanford University
Career Start Year 2004
Number of shared co-authors 5
Incyte Corporation
Career Start Year 2000
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 1999
Number of shared co-authors 3
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 11
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 1
Los Alamos National Laboratory
Career Start Year 1997
Number of shared co-authors 5
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 5
Weizmann Institute of Science
Career Start Year 1996
Number of shared co-authors 4
Accelero Biostructures Inc., USA XPose Therapeutics Inc.
Career Start Year 1996
Number of shared co-authors 0
Weizmann Institute of Science
Career Start Year 1995
Number of shared co-authors 4
Lawrence Berkeley National Laboratory
Career Start Year 1994
Number of shared co-authors 11
University of Texas Southwestern Medical Center
Career Start Year 1993
Number of shared co-authors 2
Argonne National Laboratory
Career Start Year 1993
Number of shared co-authors 5
Bridge Institute, University of Southern California
Career Start Year 1991
Number of shared co-authors 2
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 25
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 1990
Number of shared co-authors 5
University of Virginia
Career Start Year 1989
Number of shared co-authors 5
Karolinska Institutet, BioClinicum J6
Career Start Year 1989
Number of shared co-authors 3
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 6
Cambridge Institute for Medical Research, University of Cambridge
Career Start Year 1982
Number of shared co-authors 7
The State University of New Jersey
Career Start Year 1982
Number of shared co-authors 14
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 3
Los Alamos National Laboratory
Career Start Year 1980
Number of shared co-authors 9
Center for Structural Biology of Infectious Diseases, University of Chicago
Career Start Year 1979
Number of shared co-authors 12
The State University of New Jersey
Career Start Year 1975
Number of shared co-authors 7
Rice University
Career Start Year 1974
Number of shared co-authors 5
Heartand Lung Research Institute, University of Cambridge
Career Start Year 1971
Number of shared co-authors 5
Columbia University
Career Start Year 1968
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 1968
Number of shared co-authors 9
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 11

Collaborators

Stony Brook University
Co-authored papers 32
Boston University
Co-authored papers 32
Boston University
Co-authored papers 19
Amgen Inc.
Co-authored papers 7
Xijing Hospital, The Fourth Military Medical University
Co-authored papers 7
University of Oxford
Co-authored papers 7
Boston University
Co-authored papers 5
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
University of Oxford
Co-authored papers 3
Harwell Science & Innovation Campus
Co-authored papers 3
University of Massachusetts Medical School
Co-authored papers 2
Bijvoet Center for Biomolecular Research, Utrecht University
Co-authored papers 2
Pontificia Universidad Javeriana
Co-authored papers 2
European Bioinformatics Institute
Co-authored papers 2
Co-authored papers 2
Huazhong University of Science and Technology
Co-authored papers 2
University of Illinois Chicago
Co-authored papers 2
Purdue University
Co-authored papers 2
Skolkovo Institute of Science and Technology
Co-authored papers 2
University of Maryland Institute for Bioscience and Biotechnology Research
Co-authored papers 2
Dalton Cardiovascular Research Center, University of Missouri
Co-authored papers 2
Visterra Inc.
Co-authored papers 2
Utrecht University
Co-authored papers 2
GSK Medicines Research Centre
Co-authored papers 2
MGH/Harvard Medical School
Co-authored papers 2
Interdisciplinary Research Center HALOmem, Martin Luther University Halle-Wittenberg
Co-authored papers 2
VIB-VUB Center for Structural Biology
Co-authored papers 2
Co-authored papers 2